Nature Reviews Rheumatology 14, 107–119 (2018)
In the original version of this article, the indicated dosage of colchicine, 1.5 mg per day, was incorrectly given as 1.5 mg/kg per day in figure 4. This error has now been corrected in the print, PDF and HTML versions of this article.
Additional information
The online version of the original article can be found at 10.1038/nrrheum.2017.208
Rights and permissions
About this article
Cite this article
Yazici, H., Seyahi, E., Hatemi, G. et al. Erratum: Behçet syndrome: a contemporary view. Nat Rev Rheumatol 14, 119 (2018). https://doi.org/10.1038/nrrheum.2018.3
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2018.3
This article is cited by
-
Disease and Treatment-Specific Complications of Behçet Syndrome
Current Rheumatology Reports (2024)
-
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome
American Journal of Clinical Dermatology (2023)
-
Assoziation der verschiedenen Uveitisformen mit entzündlich rheumatischen Erkrankungen und ihre Therapie
Die Ophthalmologie (2023)
-
Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet’s dısease
Clinical and Experimental Medicine (2023)
-
Assoziation der verschiedenen Uveitisformen mit entzündlich rheumatischen Erkrankungen und ihre Therapie
Zeitschrift für Rheumatologie (2022)
